2019
DOI: 10.1089/jmf.2018.0087
|View full text |Cite
|
Sign up to set email alerts
|

New Insights in Purinergic Therapy: Novel Antagonists for Uridine 5′-Triphosphate-Activated P2Y Receptors from Brazilian Flora

Abstract: P2Y2 and P2Y4 receptors are physiologically activated by UTP and are widely expressed in many cell types in humans. They promote an increase in intracellular calcium via PLCβ/ IP3 and act on ion flux and water secretion. P2Y2 plays an important role in inflammation and proliferation of tumor cells, which could be attenuated with the use of antagonists. However, little is known about the physiological functions related to P2Y4 due to the lack of selective ligands for these receptors, which can be solved through… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…Plant extracts of Joannesia princeps Vell. (stem) and Peixotoa A. Juss (flower and leaf) were reported to inhibit UTP-induced responses via P2Y 2 R and P2Y 4 R, but the identification of the active molecules is still pending …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Plant extracts of Joannesia princeps Vell. (stem) and Peixotoa A. Juss (flower and leaf) were reported to inhibit UTP-induced responses via P2Y 2 R and P2Y 4 R, but the identification of the active molecules is still pending …”
Section: Introductionmentioning
confidence: 99%
“…(stem) and Peixotoa A. Juss (flower and leaf) were reported to inhibit UTP-induced responses via P2Y 2 R and P2Y 4 R, but the identification of the active molecules is still pending. 33 The scarcity of potent, druglike antagonists for the P2Y 2 R reflects the obstacles in drug discovery and ligand optimization for this target. In the present study, we report on the first homology model-based approach for the discovery of novel antagonist scaffolds for the P2Y 2 R. Based on docking predictions of the orthosteric antagonist 10, a virtual screening campaign with over 3,200,000 compounds was performed.…”
Section: Introductionmentioning
confidence: 99%